Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study

被引:252
作者
Lahoz, C
Schaefer, EJ
Cupples, LA
Wilson, PWF
Levy, D
Osgood, D
Parpos, S
Pedro-Botet, J
Daly, JA
Ordovas, JM
机构
[1] Tufts Univ, Lipid Metab Lab, USDA, Jean Mayer Human Nutr Res Ctr, Boston, MA 02111 USA
[2] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA
[3] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA
关键词
apolipoprotein E; cardiovascular disease; lipoproteins; genetic variation; population studies;
D O I
10.1016/S0021-9150(00)00570-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Apolipoprotein (apo) E is a constituent of lipoproteins with considerable variation due to cysteine-arginine exchanges. The apo E4 (Arg112-Cys) polymorphism has been associated with dementia and hypercholesterolemia. We investigated the relation of APOE genotype to cardiovascular disease (CVD) in the Framingham Offspring Study. Methods and results: DNA was isolated from 3413 study participants and APOE genotypes were determined utilizing the polymerase chain reaction and restriction isotyping. In the entire group of subjects, 20.7% had apo E4/4 or E3/4 (Group E4), 14.1%, had apo E2/2 or E2/3 (Group E2) and 63.9% had the apo E3/3 genotype (Group E3). Subjects with E2/4 (1.3%) were excluded. Period prevalence of CVD between examinations 1 and 5 (1971-1994) (366 events) was related to APOE genotype. Age adjusted period prevalence of CVD in men was 18.6% for Group E4, 18.2%, for Group E2 and 13.7%. For Group E3 (P = 0.004): while in women these rates were 9.9. 4.9. and 6.6%. respectively (P = 0.037). After adjustment for non-lipid risk factors the relative odds for CVD in Group E2 men was 1.79 (P = 0.0098) and in Group E4 it was 1.63 (P = 0.0086) compared with the Group E3, while in Group E4 women it was 1.56 (P = 0.054). After adjustment for all CVD risk factors, the relative odds in Group E2 men was 1.94 (P = 0.004) and in Group E4 men it was 1.51 (P = 0.0262). Conclusions: The presence of the apo E2 or apo E4 alleles in men is associated with significantly greater CVD risk. This genotypic information may help to identify individuals at increased risk for CVD events. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:529 / 537
页数:9
相关论文
共 69 条
[1]   The apolipoprotein E4 allele is not associated with an abnormal lipid profile in a Native American population following its traditional lifestyle [J].
Aguilar, CA ;
Talavera, G ;
Ordovas, JM ;
Barriguete, JA ;
Guillén, LE ;
Leco, ME ;
Pedro-Botet, J ;
Gonzalez-Barranco, J ;
Gómez-Pérez, FJ ;
Rull, JA .
ATHEROSCLEROSIS, 1999, 142 (02) :409-414
[2]  
[Anonymous], 1951, AM J PUBLIC HEALTH
[3]   Association of genetic polymorphisms in the ACE, ApoE, and TGFβ genes with early onset ischemic heart disease [J].
Biggart, S ;
Chin, D ;
Fauchon, M ;
Cardew, G ;
du Fou, L ;
Harker, N ;
Quinn, E ;
Keller, C ;
Vincent, R ;
Mayne, L .
CLINICAL CARDIOLOGY, 1998, 21 (11) :831-836
[4]   Lipid profiles reflecting high and low risk for coronary heart disease: Contribution of apolipoprotein E polymorphism and lifestyle [J].
Boer, JMA ;
Feskens, EJM ;
Schouten, EG ;
Havekes, LM ;
Seidell, JC ;
Kromhout, D .
ATHEROSCLEROSIS, 1998, 136 (02) :395-402
[5]  
BOERWINKLE E, 1994, AM J HUM GENET, V54, P341
[6]   APOLIPOPROTEIN(A) GENE ACCOUNTS FOR GREATER THAN 90-PERCENT OF THE VARIATION IN PLASMA LIPOPROTEIN(A) CONCENTRATIONS [J].
BOERWINKLE, E ;
LEFFERT, CC ;
LIN, JP ;
LACKNER, C ;
CHIESA, G ;
HOBBS, HH .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :52-60
[7]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[8]   Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM [J].
Brussaard, HE ;
Leuven, JAG ;
Frolich, M ;
Kluft, C ;
Krans, HMJ .
DIABETOLOGIA, 1997, 40 (07) :843-849
[9]   Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults [J].
Cattin, L ;
Fisicaro, M ;
Tonizzo, M ;
Valenti, M ;
Danek, GM ;
Fonda, M ;
DaCol, PG ;
Casagrande, S ;
Pincetti, E ;
Bovenzi, M ;
Baralle, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) :91-94
[10]   Apolipoprotein E genotype and plasma levels in coronary artery disease. A case-control study in the Italian population [J].
Corbo, RM ;
Vilardo, T ;
Ruggeri, M ;
Gemma, AT ;
Scacchi, R .
CLINICAL BIOCHEMISTRY, 1999, 32 (03) :217-222